Page last updated: 2024-09-03

2'-cyano-2'-deoxyarabinofuranosylcytosine and Leukemia P388

2'-cyano-2'-deoxyarabinofuranosylcytosine has been researched along with Leukemia P388 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azuma, A; Hanaoka, K; Kamo, N; Kobayashi, T; Kurihara, A; Matsuda, A; Miyauchi, S; Sasaki, T; Tanaka, M1
Hanaoka, K; Hisaoka, M; Ikeda, T; Iwabuchi, H; Kaneko, M; Kobayashi, T; Kurakata, S; Matsuda, A; Mitsuhashi, Y; Miura, S; Nakagawa, A; Nomura, T; Sasaki, T; Shibayama, T; Suzuki, M; Tanaka, K; Tanzawa, F; Tomida, A; Tsuruo, T; Wataya, Y1
Matsuda, A; Sasaki, T; Tanaka, M; Terao, T1
Azuma, A; Matsuda, A; Nakajima, Y; Sasaki, T; Tanaka, M1

Other Studies

4 other study(ies) available for 2'-cyano-2'-deoxyarabinofuranosylcytosine and Leukemia P388

ArticleYear
Nucleosides and nucleotides. 141. Chemical stability of a new antitumor nucleoside, 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine in alkaline medium: formation of 2'-C-cyano-2'-deoxy-1-beta-D-ribo-pentofuranosylcytosine and its antitumor act
    Journal of medicinal chemistry, 1995, Aug-18, Volume: 38, Issue:17

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Division; Colonic Neoplasms; Cytarabine; Drug Stability; Female; Humans; Hydrogen-Ion Concentration; Leukemia P388; Mice; Mice, Inbred DBA; Ribonucleosides; Spectrum Analysis; Tumor Cells, Cultured

1995
Antitumor activity and novel DNA-self-strand-breaking mechanism of CNDAC (1-(2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl) cytosine) and its N4-palmitoyl derivative (CS-682).
    International journal of cancer, 1999, Jul-19, Volume: 82, Issue:2

    Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Arabinonucleosides; Biotransformation; Breast Neoplasms; Cisplatin; Cytarabine; Cytosine; Deoxycytidine; Deoxycytidine Kinase; DNA Damage; DNA, Neoplasm; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; KB Cells; Leukemia P388; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Nude; Mitomycin; Molecular Structure; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Experimental; Rats; Rats, Nude; Specific Pathogen-Free Organisms; Stomach Neoplasms; Tumor Cells, Cultured; Vincristine

1999
Antitumor activity of a novel nucleoside, 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine (CNDAC) against murine and human tumors.
    Cancer letters, 1992, May-30, Volume: 64, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Survival; Chick Embryo; Cytarabine; Cytidine Deaminase; Humans; Leukemia P388; Mice; Mice, Nude; Tumor Cells, Cultured

1992
Nucleosides and nucleotides. 100. 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosyl-cytosine (CNDAC): design of a potential mechanism-based DNA-strand-breaking antineoplastic nucleoside.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:9

    Topics: Animals; Antineoplastic Agents; Cytarabine; DNA; Drug Design; Drug Screening Assays, Antitumor; Leukemia P388; Mice; Tumor Cells, Cultured

1991